Basic Information
Source of strain: Isolated from mouse intestine
Patented Culture Collection Number: PTA-124205
Product Standard:5.0E11 CFU/g (500 billion CFU/g)
Gene identification: 16S rRNA identification/ Whole genome
US Patent: US 10,413,577 B2 US 10,028,983 B2
Features
1.Highly stomach acid and pepsin resistant
2.Highly bile salt resistant
3.Great cell adhersion
4.Great shelf life viability
5.Anti pathogens capacity
Health effects
Anti inflammation
Anti cancer
Anti pathogens
Mechanisms
• Lactobacillus johnsonii LBJ 456TM treatment reduces DNA damage in ATM -/- mice.
• LBJ 456TM treatment decreases inflammatory cytokine levels in both blood and liver : IL-1beta, IL-12, and IFN-g.
• LBJ 456TM treatment increases levels of IL-4, IL-10, and TGF-beta, which enable inflammatory control, especially in the liver